| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 8.41B | — |
| Operating expense | — | — |
| Net income | 1.57B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MARKSANS.NS returned +81.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +79.2% |
| 1 year | +81.7% |
| 5 years | +365.0% |
| 10 years | +715.8% |
| All-time high | ₹342.75 (Nov 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in MARKSANS.NS would be worth today ›Yes. Marksans Pharma Limited paid 1 dividend over the past 12 months. The most recent was ₹0.90 per share on Aug 20, 2026. The dividend yield is 0.28%.
Marksans Pharma Limited is part of the Healthcare sector.
Marksans Pharma Limited has a market cap of 146.01B INR, based on the latest quote.
